 Philip Morris International Inc. PM, -3.73 said Wednesday that it has appointed two former officials with the U.S. Food and Drug Administration to positions that will accelerate the cigarette makers transition to a smoke-free future. The company said it has appointed Dr. Badrul Chowdhury, who was a regulator in the FDAs pulmonary division, as its chief life sciences officer, and will join Philip Morris senior management team in January 2023. 